Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.
<h4>Objective</h4>This article describes the Personalized Reimbursement Model (PRM) program methodology, limitations, achievement and perspectives in using real-world data of cancer drugs use to improve and personalize drug pricing and reimbursement in France.<h4>Materials and meth...
Main Authors: | Pierre-Alexandre Squara, Vinh-Phuc Luu, David Pérol, Bruno Coudert, Valérie Machuron, Camille Bachot, Laurence Samelson, Virginie Florentin, Jean-Marc Pinguet, Béchir Ben Hadj Yahia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0267242 |
Similar Items
-
Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01) -
New reimbursement criteria for lipid-lowering drugs
by: Mario Eandi
Published: (2011-06-01) -
Personalized Medicine’s Bottleneck: Diagnostic Test Evidence and Reimbursement
by: Joshua P. Cohen, et al.
Published: (2014-04-01) -
Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017-12-01) -
Analysis of oral hypoglycemic drugs that are subject to reimbursement in Ukraine
by: I. O. Vlasenko
Published: (2022-10-01)